Similarly, weekly intermittent “pulses” of high‐dose erlotinib (1500 mg) resulted in CSF concentrations above half‐maximal inhibitory concentrations against lung cancer cells with EGFR mutations in patients with leptomeningeal metastases.16 Here, EGFR is linked to lung carcinoma.